CSPC Dophen Corporation
Sacramento, CA, US· latest recorded location
CSPC Dophen Corporation is named on 3 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 3
- Published applications
- 4
- Inventors
- 2
- Granted in 2026 so far
- 0
- Most recent grant
- 5 May 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 2 |
| 2019 | 2 | 0 |
| 2020 | 1 | 1 |
By publication year.
Technology areas
Share of 7 documents
Recent patents
- Homogenous antibody drug conjugates via enzymatic methods5 May 2020US 10,639,291 B2
- Homogenous antibody drug conjugates via enzymatic methods12 Nov 2019US 10,471,037 B2
- Homogenous antibody drug conjugates via enzymatic methods23 Jul 2019US 10,357,472 B2
- Homogenous antibody drug conjugates via enzymatic methods23 Jan 2020US 2020/0022942 A1
- Homogenous antibody drug conjugates via enzymatic methods20 Dec 2018US 2018/0360793 A1
- Homogenous antibody drug conjugates via enzymatic methods20 Dec 2018US 2018/0360794 A1
- Homogenous antibody drug conjugates via enzymatic methods20 Apr 2017US 2017/0106096 A1
Most cited
By later US patents